Volume 58, Issue 6, Pages (June 2013)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Volume 66, Issue 4, Pages (April 2017)
Hepatitis C viral proteins perturb metabolic liver zonation
Volume 67, Issue 2, Pages (August 2017)
The BH3-Only Protein Bid Does Not Mediate Death-Receptor-Induced Liver Injury in Obstructive Cholestasis  Padmavathi devi Nalapareddy, Sven Schüngel,
Volume 58, Issue 6, Pages (June 2013)
Volume 42, Issue 1, Pages (January 2005)
Volume 125, Issue 3, Pages (September 2003)
Volume 123, Issue 5, Pages (November 2002)
Volume 62, Issue 3, Pages (March 2015)
Volume 123, Issue 4, Pages (October 2002)
Volume 63, Issue 4, Pages (October 2015)
Volume 117, Issue 3, Pages (September 1999)
Volume 44, Issue 4, Pages (April 2006)
Volume 129, Issue 2, Pages (August 2005)
Volume 53, Issue 5, Pages (November 2010)
Volume 42, Issue 1, Pages (January 2005)
Volume 67, Issue 2, Pages (August 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Volume 44, Issue 2, Pages (February 2006)
Volume 124, Issue 1, Pages (January 2003)
Volume 64, Issue 1, Pages (January 2016)
Volume 44, Issue 1, Pages (January 2006)
Volume 42, Issue 1, Pages (January 2005)
Volume 130, Issue 2, Pages (February 2006)
Volume 41, Issue 5, Pages (November 2004)
Volume 44, Issue 6, Pages (June 2006)
Angiogenesis in liver disease
Volume 62, Issue 4, Pages (April 2015)
Volume 64, Issue 3, Pages (March 2016)
Volume 44, Issue 4, Pages (April 2006)
Volume 129, Issue 5, Pages (November 2005)
Volume 129, Issue 2, Pages (August 2005)
Volume 66, Issue 1, Pages (January 2017)
Volume 42, Issue 4, Pages (April 2005)
Volume 60, Issue 6, Pages (June 2014)
Volume 42, Issue 2, Pages (February 2005)
Volume 69, Issue 2, Pages (August 2018)
Volume 41, Issue 5, Pages (November 2004)
Volume 119, Issue 6, Pages (December 2000)
Volume 39, Issue 4, Pages (October 2003)
Volume 127, Issue 6, Pages (December 2004)
Volume 44, Issue 4, Pages (April 2006)
Volume 141, Issue 1, Pages e4 (July 2011)
This Month in Gastroenterology
JNK mediates hepatic ischemia reperfusion injury
Volume 61, Issue 6, Pages (December 2014)
Volume 53, Issue 5, Pages (November 2010)
Volume 41, Issue 6, Pages (December 2004)
Volume 62, Issue 6, Pages (June 2015)
Volume 138, Issue 7, Pages (June 2010)
Volume 123, Issue 4, Pages (October 2002)
Volume 42, Issue 3, Pages (March 2005)
Volume 60, Issue 4, Pages (April 2014)
Volume 127, Issue 1, Pages (July 2004)
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Volume 59, Issue 2, Pages (August 2013)
Volume 41, Issue 6, Pages (December 2004)
Volume 44, Issue 2, Pages (February 2006)
Volume 50, Issue 3, Pages (March 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 61, Issue 6, Pages (December 2014)
Volume 124, Issue 1, Pages (January 2003)
Overexpression of Fetuin-A Counteracts Ectopic Mineralization in a Mouse Model of Pseudoxanthoma Elasticum (Abcc6−/−)  Qiujie Jiang, Florian Dibra, Michael.
Volume 62, Issue 6, Pages (June 2015)
Volume 60, Issue 1, Pages (January 2014)
Volume 44, Issue 3, Pages (March 2006)
Production of nerve growth factor by mouse hepatocellular carcinoma cells and expression of TrkA in tumor-associated arteries in mice  Kan Kishibe, Yoshihisa.
Volume 128, Issue 3, Pages (March 2005)
Matrix Metalloproteinase Inhibitor BB-3103 Unlike the Serine Proteinase Inhibitor Aprotinin Abrogates Epidermal Healing of Human Skin Wounds Ex Vivo1 
Presentation transcript:

Volume 58, Issue 6, Pages 1201-1208 (June 2013) Differential effects of norUDCA and UDCA in obstructive cholestasis in mice  Peter Fickert, Marion J. Pollheimer, Dagmar Silbert, Tarek Moustafa, Emina Halilbasic, Elisabeth Krones, Franziska Durchschein, Andrea Thüringer, Gernot Zollner, Helmut Denk, Michael Trauner  Journal of Hepatology  Volume 58, Issue 6, Pages 1201-1208 (June 2013) DOI: 10.1016/j.jhep.2013.01.026 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 1 UDCA but not norUDCA aggravates liver injury in bile duct ligated mice. (A) Experimental design: mice were fed either 0.5% UDCA, 0.5% norUDCA, or chow diet, subjected to common bile duct ligation (CBDL) or selective bile duct ligation (SBDL), and harvested 7, 10 or 14days later. Mice received bile acid-supplemented diet either at time of CBDL (Group A) or 3days past CBDL (Group B). SBDL was performed 7days after start of bile acid feeding in Swiss albino (Group C) and Abcb4−/− mice (Group D). (B) Manometric tracing in UDCA (black lozenges), norUDCA (gray squares) and chow-fed mice (open triangles). Biliary pressure in norUDCA-fed mice is higher without reaching statistical significance compared to the UDCA-fed group. Note that significant differences compared to chow-fed mice were reached at an earlier time point in norUDCA-fed mice. p<0.05: ∗CBDL vs. CBDL+UDCA. †CBDL vs. CBDL+norUDCA. (C) Liver histology of CBDL mice fed chow (Group A1), 0.5% UDCA- (Group A2) and 0.5% norUDCA-supplemented diet (Group A3) for 7days. While UDCA increases the number and size of bile infarcts (indicated by asterisks) in CBDL mice, norUDCA-feeding results in a comparable or even slightly improved histological picture. (D) Morphometric analysis reveals a significantly higher amount of bile infarcts in UDCA-fed compared to norUDCA- and chow-fed CBDL mice. (E) While UDCA significantly increases serum AP levels compared to chow- and norUDCA-fed CBDL mice, norUDCA-feeding leads to a slight AP reduction compared to chow-fed CBDL mice. Both UDCA and norUDCA significantly increase serum bile acid (SBA) levels compared to chow-fed CBDL mice. (F) Significantly reduced iNOS mRNA, hepatic neutrophil count, and hepatic hxydroxyporine levels in norUDCA-treated CBDL mice. Values are mean±SD from 3–4 animals per group. p<0.05: ∗CBDL vs. CBDL+UDCA or CBDL+norUDCA. †CBDL+UDCA vs. CBDL+norUDCA. (C) Original magnification 100×. bd, bile duct; cv, central vein; pv, portal vein. Journal of Hepatology 2013 58, 1201-1208DOI: (10.1016/j.jhep.2013.01.026) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 2 norUDCA ameliorates liver injury in CBDL mice. (A) H&E stained liver sections from mice fed chow (CBDL, Group B1), 0.5% UDCA- (CBDL+UDCA, Group B2) and 0.5% norUDCA-supplemented diet (CBDL+norUDCA, Group B3) 3days past CBDL. Note the higher number and size of bile infarcts (indicated by asterisks) in UDCA-fed mice. (B) Morphometric analysis shows a significantly higher amount of bile infarcts in UDCA-fed compared to norUDCA-fed CBDL mice. (C) Comparable ALT values between all experimental groups, while UDCA leads to an increase in AP levels, norUDCA significantly reduces AP levels compared to CBDL chow-fed mice. Both UDCA and norUDCA significantly increase serum bile acid (SBA) levels in CBDL mice compared to CBDL chow-fed mice. (D) Significantly reduced iNOS mRNA levels, hepatic neutrophil count, and hepatic hydrocyproline levels in the norUDCA group. Values are mean±SD from 8–9 animals per group. p<0.05: ∗CBDL vs. CBDL+UDCA or CBDL+norUDCA. †CBDL+UDCA vs. CBDL+norUDCA. (A) Original magnification 100×. bd, bile duct; cv, central vein; pv, portal vein. Journal of Hepatology 2013 58, 1201-1208DOI: (10.1016/j.jhep.2013.01.026) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 3 UDCA but not norUDCA aggravates bile infarcts of ligated lobes in SBDL mice. (A) Macroscopic appearance of the hepatic facies visceralis and H&E stained liver sections in chow-fed SBDL liver (SBDL, Group C1), UDCA-fed SBDL liver (SBDL+UDCA, Group C2), and norUDCA-fed SBDL liver (SBDL+norUDCA, Group C3). Note that only the UDCA-fed mouse shows bile infarcts (white circles) in SBDL lobes. Note periductal edema and ductular reaction under all experimental situations. Notably, only the UDCA-fed SBDL liver shows bile infarcts (indicated by asterisks). (B) Morphometric analysis shows a significantly higher amount of bile infarcts in UDCA-fed mice. (C) Differences in serum ALT and PP values did not reach statistical significance. Both UDCA and norUDCA cause a significant increase in serum bile acid (SBA) in SBDL mice. p<0.05: ∗CBDL vs. CBDL+UDCA or CBDL+norUDCA. †CBDL+UDCA vs. CBDL+norUDCA. (D) Significant reduced neutrophil count and hepatic hydroxyproline content in the norUDCA group. Values are mean±SD from 3–4 animals per group. p<0.05: ∗SBDL vs. SBDL+UDCA or SBDL+norUDCA. †SBDL+UDCA vs. SBDL+norUDCA. (A lower panel) original magnification 100×. bd, bile duct; cv, central vein; pv, portal vein. Journal of Hepatology 2013 58, 1201-1208DOI: (10.1016/j.jhep.2013.01.026) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 4 UDCA but not norUDCA aggravates bile infarcts of ligated lobes in SBDL Abcb4−/− mice. (A) Macroscopic liver appearance in the UDCA-fed SBDL liver (SBDL+UDCA, Group D1) and norUDCA-fed SBDL liver of Abcb4−/− mice (SBDL+norUDCA, Group D2). Bile infarcts (indicated by black arrowheads) can be detected only in the ligated lobe (white circles) of UDCA-fed mice. Liver histology (H&E staining) reveals periductal edema and ductular reaction under all experimental situations, but only the UDCA-fed SBDL liver shows bile infarcts (indicated by asterisks). (B) Morphometric analysis shows a significant increase in the amount of bile infarcts in the ligated and non-ligated lobes of UDCA- compared to norUDCA-fed Abcb4−/− mice under SBDL. (C) UDCA significantly increases serum AP levels compared to norUDCA-fed SBDL Abcb4−/− mice whereas ALT levels are comparable. (D) Significantly reduced neutrophil count in the norUDCA groups whereas differences in hepatic hydroxyproline levels did not reach statistical significance. (E) Ductular reaction in ligated lobes of SBDL Abcb4−/− mice. Immunohistochemical staining of bile duct epithelial cells by using an anti-K19 antibody. Note that only the ligated lobes (lower panel) show ductular reaction under all experimental conditions. Bile infarcts (indicated by asterisks) are only detected in UDCA-fed SBDL Abcb4−/− mice. (F) Western blot analyses of hepatic Vcam-1, α-SMA and K19 protein levels. Note a significant decrease in Vcam-1 and K19 protein levels in the ligated lobes of norUDCA-fed Abcb4−/− mice (n.c., negative control, representing loaded liver protein without respective primary antibodies; p.c., positive control, representing liver of untreated Abcb4−/− mouse). (A lower panel and D) Original magnification 100×. cv, central vein; pv, portal vein. Values are mean±SD from 3–4 animals per group. p<0.05: †SBDL+UDCA vs. SBDL+norUDCA. Journal of Hepatology 2013 58, 1201-1208DOI: (10.1016/j.jhep.2013.01.026) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions